The largest database of trusted experimental protocols

Verikine human interferon alpha elisa kit

Manufactured by PBL Assay Science
Sourced in United States

The VeriKine Human Interferon Alpha ELISA Kit is a laboratory assay used to detect and quantify levels of interferon alpha in human samples. It is an enzyme-linked immunosorbent assay (ELISA) that employs antibodies specific to interferon alpha to measure its concentration.

Automatically generated - may contain errors

3 protocols using verikine human interferon alpha elisa kit

1

PBMC Cytokine Response to Microbial Stimuli

Check if the same lab product or an alternative is used in the 5 most similar protocols
5x105 PBMCs per well were seeded in U-bottom 96-well tissue culture plates (Greiner Bio-One, Austria) and stimulated with 10 ng/ml lipopolysaccharides (LPS) derived from Escherichia coli O55:B5 (Sigma-Aldrich, MO, USA), 106/ml heat-killed Staphylococcus aureus, 106/ml heat-killed Candida albicans, R848 (InvivoGen), or heat-inactivated(30 minutes, 60°C) SARS-CoV-2 Wuhan-Hu-1 strain (NRW-42 isolate, GISAID accession number: EPI_ISL_425126) (35 (link)) with 1 µg/ml soluble purified mouse anti-human CD28 (BD Biosciences, New Jersey, USA), for 24 hours and 7 days in the presence of 10% pooled human serum. A control condition without any stimulant was included. Cells were incubated at 37°C with 5% CO2. Stimulations with R848 and SARS-CoV-2 were performed later with cryopreserved cells, while the rest of the stimulations were done with freshly isolated PBMCs. Concentrations of TNF-α, IL-6, IL-1β, IL-1Ra, and IFN-γ in culture supernatants were determined using DuoSet ELISA kits (R&D Systems, MN, USA). IFNα concentrations were determined using VeriKine Human Interferon Alpha ELISA Kit (PBL Assay Science, NJ, USA) according to the manufacturer’s instructions. Supernatants from 7 days stimulations were used for IFN-γ, and the remaining cytokines were measured in 24-hour supernatants.
+ Open protocol
+ Expand
2

Pharmacokinetics of Interferon Alpha Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
In consenting patients, serial serum samples (3 mL) for pharmacokinetic studies of IFN α-2b were collected before the first dose week 1, day 1 of induction therapy and 1, 2, 4, 6, 8, 12 and 24 hours post infusion. Serial serum samples (3 mL) for pharmacokinetic studies of pegylated IFN α-2b were collected during maintenance therapy before the first dose and 24, 96 and 168 hours after the dose during weeks 5 and 28. In addition, pre-dose serum samples for pegylated IFN α-2b were collected on weeks 8, 12, 16, 44, and 52. Samples were analyzed for IFN α-2b or pegylated IFN α-2b concentrations by using the VeriKine Human Interferon Alpha ELISA Kit (PBL Assay Science) following the manufacturer’s instructions and concentration-time data were analyzed by nonlinear-mixed effects modeling as implemented in NONMEM 7.3.[23 ] Details are provided in Supplementary Materials.
+ Open protocol
+ Expand
3

Cytokine Profiling in PBMC Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Production of secreted cytokines in PBMC culture supernatants was measured using ELISA. IL-1β, IL-6, TNF, CXCL10, interleukin-10 (IL-10), interleukin-1 receptor antagonist (IL-1Ra), and interferon-gamma (IFN-γ) concentrations were determined with duoSet ELISA kits (R&D Systems). The VeriKine Human Interferon Alpha ELISA Kit (PBL Assay Science) was used to measure interferon-alfa (IFN-α). Supernatants from 7-day cultures were used for IFN-γ measurements, whereas the remaining cytokines were measured in 24-hour culture supernatants. Plasma concentrations of Interferon Stimulated Gene 15 (ISG15) were measured using the Human ISG15 ELISA kit from Elabscience (Elabscience). All tests were performed according to the instructions of the manufacturer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!